Van Eck Associates Corp Vertex Pharmaceuticals Inc Transaction History

Van Eck Associates Corp

  • $78.1 Billion
  • Q4 2024

A detailed history of Van Eck Associates Corp transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 159,269 shares of VRTX stock, worth $76.7 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
159,269
Previous 151,428 5.18%
Holding current value
$76.7 Million
Previous $71.2 Million 9.89%
% of portfolio
0.08%
Previous 0.09%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025
BUY
$396.64 - $516.74 $3.11 Million - $4.05 Million
7,841 Added 5.18%
159,269 $64.1 Million
Q3 2024

Oct 29, 2024
BUY
$460.0 - $505.78 $3.03 Million - $3.33 Million
6,588 Added 4.55%
151,428 $71.2 Million
Q2 2024

Jul 31, 2024
SELL
$392.81 - $485.53 $2.77 Million - $3.43 Million
-7,058 Reduced 4.65%
144,840 $67.9 Million
Q1 2024

Apr 30, 2024
SELL
$407.69 - $446.08 $9.1 Million - $9.96 Million
-22,329 Reduced 12.82%
151,898 $63.5 Million
Q4 2023

Feb 05, 2024
BUY
$343.0 - $410.68 $7.02 Million - $8.4 Million
20,466 Added 13.31%
174,227 $70.9 Million
Q3 2023

Nov 08, 2023
SELL
$338.18 - $362.46 $3.51 Million - $3.76 Million
-10,368 Reduced 6.32%
153,761 $53.5 Million
Q2 2023

Aug 03, 2023
SELL
$314.42 - $351.91 $3.63 Million - $4.06 Million
-11,535 Reduced 6.57%
164,129 $57.8 Million
Q1 2023

May 03, 2023
BUY
$283.23 - $323.1 $3.4 Million - $3.88 Million
12,001 Added 7.33%
175,664 $55.3 Million
Q4 2022

Feb 08, 2023
SELL
$285.76 - $321.48 $3.29 Million - $3.7 Million
-11,507 Reduced 6.57%
163,663 $47.3 Million
Q3 2022

Oct 27, 2022
BUY
$273.83 - $305.53 $3.9 Million - $4.35 Million
14,239 Added 8.85%
175,170 $50.7 Million
Q2 2022

Aug 03, 2022
BUY
$234.96 - $292.55 $3.81 Million - $4.74 Million
16,201 Added 11.19%
160,931 $45.3 Million
Q1 2022

May 10, 2022
SELL
$221.42 - $260.97 $3.28 Million - $3.86 Million
-14,792 Reduced 9.27%
144,730 $37.8 Million
Q4 2021

Jan 26, 2022
SELL
$177.01 - $223.45 $3.48 Million - $4.39 Million
-19,656 Reduced 10.97%
159,522 $35 Million
Q3 2021

Nov 03, 2021
BUY
$181.39 - $202.99 $6.87 Million - $7.69 Million
37,885 Added 26.81%
179,178 $32.5 Million
Q2 2021

Aug 10, 2021
BUY
$187.49 - $221.1 $3.83 Million - $4.51 Million
20,403 Added 16.88%
141,293 $28.5 Million
Q1 2021

May 13, 2021
BUY
$207.02 - $241.31 $1.83 Million - $2.13 Million
8,816 Added 7.87%
120,890 $26 Million
Q4 2020

Feb 09, 2021
BUY
$207.01 - $276.09 $2.47 Million - $3.3 Million
11,937 Added 11.92%
112,074 $26.5 Million
Q3 2020

Nov 12, 2020
SELL
$255.65 - $303.1 $1.39 Million - $1.65 Million
-5,440 Reduced 5.15%
100,137 $27.2 Million
Q2 2020

Aug 10, 2020
BUY
$225.48 - $295.8 $6.95 Million - $9.12 Million
30,833 Added 41.25%
105,577 $30.7 Million
Q1 2020

May 12, 2020
SELL
$199.77 - $247.81 $3.06 Million - $3.8 Million
-15,326 Reduced 17.02%
74,744 $17.8 Million
Q4 2019

Feb 13, 2020
SELL
$166.71 - $223.91 $2.34 Million - $3.14 Million
-14,013 Reduced 13.46%
90,070 $19.7 Million
Q3 2019

Nov 08, 2019
SELL
$166.23 - $187.09 $1.12 Million - $1.26 Million
-6,728 Reduced 6.07%
104,083 $17.6 Million
Q2 2019

Aug 07, 2019
SELL
$164.61 - $190.37 $924,614 - $1.07 Million
-5,617 Reduced 4.82%
110,811 $20.3 Million
Q1 2019

May 13, 2019
BUY
$163.73 - $194.7 $192,219 - $228,577
1,174 Added 1.02%
116,428 $21.4 Million
Q4 2018

Feb 12, 2019
SELL
$151.91 - $192.21 $2.13 Million - $2.7 Million
-14,048 Reduced 10.86%
115,254 $19.1 Million
Q3 2018

Nov 13, 2018
SELL
$167.73 - $192.74 $1.78 Million - $2.04 Million
-10,602 Reduced 7.58%
129,302 $24.9 Million
Q2 2018

Aug 13, 2018
BUY
$145.72 - $169.96 $990,750 - $1.16 Million
6,799 Added 5.11%
139,904 $23.8 Million
Q1 2018

May 11, 2018
SELL
$151.6 - $177.13 $8.62 Million - $10.1 Million
-56,839 Reduced 29.92%
133,105 $21.7 Million
Q4 2017

Feb 12, 2018
SELL
$137.28 - $155.55 $2.39 Million - $2.7 Million
-17,388 Reduced 8.39%
189,944 $28.5 Million
Q3 2017

Nov 09, 2017
SELL
$148.13 - $162.24 $3.68 Million - $4.03 Million
-24,813 Reduced 10.69%
207,332 $31.5 Million
Q2 2017

Aug 11, 2017
BUY
N/A
232,145
232,145 $29.9 Million

Others Institutions Holding VRTX

# of Institutions
1,753
Shares Held
227M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $124B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email